Longitudinal SARS-CoV-2 humoral response in MS patients with and without SARS-CoV-2 infection prior to vaccination › Research Explorer

DOI

https://doi.org/10.3389/fneur.2022.1032830
Final published version

the T2B! immunity against SARS-CoV-2 study group

Original language	English
Article number	1032830
Journal	Frontiers in neurology
Volume	13
DOIs	https://doi.org/10.3389/fneur.2022.1032830
Publication status	Published - 10 Nov 2022

Research areas

COVID-19, SARS-CoV-2, disease modifying treatment, humoral response, multiple sclerosis

ID: 28415109